Carmen Antunez
Overview
Explore the profile of Carmen Antunez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
2505
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martinez-Lopez S, Tabone M, Clemente-Velasco S, Gonzalez-Soltero M, Bailen M, De Lucas B, et al.
J Alzheimers Dis
. 2024 Nov;
102(4):943-966.
PMID: 39584279
Background: Alzheimer's disease (AD) presents a significant challenge in healthcare, prompting exploration into non-pharmacological interventions to complement traditional treatments. Objective: This systematic review explores the efficacy of lifestyle-based interventions in...
2.
de Rojas I, Moreno-Grau S, Tesi N, Grenier-Boley B, Andrade V, Jansen I, et al.
Nat Commun
. 2023 Feb;
14(1):716.
PMID: 36759603
No abstract available.
3.
Bellenguez C, Kucukali F, Jansen I, Kleineidam L, Moreno-Grau S, Amin N, et al.
Nat Genet
. 2022 Apr;
54(4):412-436.
PMID: 35379992
Characterization of the genetic landscape of Alzheimer's disease (AD) and related dementias (ADD) provides a unique opportunity for a better understanding of the associated pathophysiological processes. We performed a two-stage...
4.
de Rojas I, Moreno-Grau S, Tesi N, Grenier-Boley B, Andrade V, Jansen I, et al.
Nat Commun
. 2021 Jun;
12(1):3417.
PMID: 34099642
Genetic discoveries of Alzheimer's disease are the drivers of our understanding, and together with polygenetic risk stratification can contribute towards planning of feasible and efficient preventive and curative clinical trials....
5.
Moreno-Grau S, Fernandez M, de Rojas I, Garcia-Gonzalez P, Hernandez I, Farias F, et al.
Transl Psychiatry
. 2021 Feb;
11(1):142.
PMID: 33627629
Long runs of homozygosity (ROH) are contiguous stretches of homozygous genotypes, which are a footprint of inbreeding and recessive inheritance. The presence of recessive loci is suggested for Alzheimer's disease...
6.
Sanchez-Campillo M, Ruiz-Pastor M, Gazquez A, Marin-Munoz J, Noguera-Perea F, Ruiz-Alcaraz A, et al.
Int J Mol Sci
. 2019 Dec;
21(1).
PMID: 31861865
The protein Major Facilitator Superfamily Domain containing 2A (MFSD2a) was recently described as the primary carrier for docosahexaenoic acid (DHA) into the brain. Alzheimer's disease (AD) is a progressive neurodegenerative...
7.
Moreno-Grau S, de Rojas I, Hernandez I, Quintela I, Montrreal L, Alegret M, et al.
Alzheimers Dement
. 2019 Sep;
15(10):1333-1347.
PMID: 31473137
Introduction: Large variability among Alzheimer's disease (AD) cases might impact genetic discoveries and complicate dissection of underlying biological pathways. Methods: Genome Research at Fundacio ACE (GR@ACE) is a genome-wide study...
8.
Moreno-Grau S, Hernandez I, Heilmann-Heimbach S, Ruiz S, Rosende-Roca M, Mauleon A, et al.
Oncotarget
. 2018 Jun;
9(37):24590-24600.
PMID: 29872490
The apolipoprotein E () gene on chromosome 19q13.32, was the first, and remains the strongest, genetic risk factor for Alzheimer's disease (AD). Additional signals associated with AD have been located...
9.
Sanchez-Benavides G, Pena-Casanova J, Casals-Coll M, Gramunt N, Manero R, Puig-Pijoan A, et al.
Arch Clin Neuropsychol
. 2016 May;
31(4):378-88.
PMID: 27193368
Objective: Serial cognitive assessments are useful for many purposes, such as monitoring cognitive decline or evaluating the result of an intervention. In order to determine if an observed change is...
10.
Alcolea D, Martinez-Lage P, Sanchez-Juan P, Olazaran J, Antunez C, Izagirre A, et al.
Neurology
. 2015 Jul;
85(7):626-33.
PMID: 26180139
Objective: To investigate CSF markers involved in amyloid precursor protein processing, neuronal damage, and neuroinflammation in the preclinical stages of Alzheimer disease (AD) and participants with suspected non-Alzheimer pathology (SNAP)....